Strategic Forecasting in the Pharmaceutical Industry: A 2-Day Interactive Training
@Leonardo Royal Hotel, St. Pauls, London
groupH is dedicated to providing pharma, biotech companies and investors with strategic insights and bespoke company forecasts at both early and late stage of product development.
Do I develop my asset for the right indications? Have I done everything possible to maximise the inherent value of my asset within its lifecycle? How are commercial forecasts put together and used as a strategic tool?
To help answer those questions Erik Holzinger and Lise Thomalla are providing an in-person training course to develop an understanding of how strategy can be incorporated into forecasts. This includes determining the range of potentially attractive indications at very early stages of development and assessing a variety of competitor, TPP, market or other scenarios, with the objective of optimizing the value of an asset within increasingly competitive environments and shorter life cycles.
If you have any further questions please do contact erik.holzinger@grouph.com or lise.thomalla@grouph.com
